Animal Cancer Dx

CEO Chan Namgong

Animal Cancer Dx is a Raleigh-based chemical and biomolecular diagnostic company committed to pioneering early detection of cancer in dogs with a drop of a urine sample. The company’s patent-pending scientific test, A.C.D. Test™, combines its proprietary metabolomics technology and C. elegans’ highly effective olfactory receptors to detect cancerous VOCs. As a one-of-a-kind multi cancer early detection test, it’s a convenient, non-invasive, cost-effective, and highly accurate cancer detection test available to canine patients.